Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
681 Signet ring carcinoma of the stomach: impact on prognosis and outcome
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2018
682 Outcomes of Early-stage Glottic Carcinoma Treated with Radiation Therapy: A Single Institution Experience Department of Radiotherapy and Nuclear medicine Dr. Moamen Mohamed Omran Moustafa Aly 2018
683 Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder. Department of Biostatistics and Cancer Epidemiology Nabiel Nazmi Hanna Mikhail 2018
684
Effect of Acid Suppression on Peripheral T-Lymphocyte Subsets and Immunohistochemical Esophageal Mucosal Changes in Patients With Gastroesophageal Reflux Disease.
 		Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2018
685 circulating mi RNA-21 and miRNA-23 expression signature as potential biomarkers for early detection of non-small cell lung cancer Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2018
686 Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder. Department of Biostatistics and Cancer Epidemiology Nabiel Nazmi Hanna Mikhail 2018
687 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Department of Pediatric Oncology Dr. Khaled Fathy Riad Osman 2018
688 HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2018
689 Comparison of nebulised dexmedetomidine,
ketamine, or midazolam for premedication in
preschool children undergoing bone marrow biopsy 		Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2018
690 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Department of Pediatric Oncology Dr. Shaimaa / Elsayyed Youssef / Ahmed 2018